Dalriada Drug Discovery Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
71
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Dalriada Drug Discovery General Information
Description
Provider of integrated drug discovery services intended for biotechnology and pharmaceutical companies. The company's turnkey model utilizes medicinal chemistry, biological research, and a proprietary live-cell proteomics platform to accelerate the development of small-molecule therapies from initial concept through lead optimization and clinical evaluation.
Contact Information
Website
www.dalriadatx.comCorporate Office
- 2820 Argentia Road
- Unit 8-9
- Mississauga, Ontario L5N 8G4
- Canada
Corporate Office
- 2820 Argentia Road
- Unit 8-9
- Mississauga, Ontario L5N 8G4
- Canada
Dalriada Drug Discovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 01-Aug-2026 | Completed | Generating Revenue | |||
| 9. Grant | 13-Nov-2020 | Completed | Generating Revenue | |||
| 8. Grant | 06-Feb-2018 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series A) | 02-Jun-2017 | Completed | Generating Revenue | |||
| 6. Angel (individual) | Completed | Generating Revenue | ||||
| 5. Accelerator/Incubator | 06-Apr-2017 | Completed | Generating Revenue | |||
| 4. Grant | 04-Apr-2017 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2017 | $74.8K | $74.8K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Dalriada Drug Discovery Patents
Dalriada Drug Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3113532-A1 | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof | Inactive | 21-Sep-2017 | ||
| EP-3684754-A1 | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof | Inactive | 21-Sep-2017 | ||
| EP-3684754-A4 | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof | Inactive | 21-Sep-2017 | ||
| US-20200277268-A1 | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof | Inactive | 21-Sep-2017 | ||
| WO-2019056120-A1 | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof | Inactive | 21-Sep-2017 | C07C311/20 |
Dalriada Drug Discovery Signals
Dalriada Drug Discovery Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Toronto | University | Minority |
Dalriada Drug Discovery FAQs
-
When was Dalriada Drug Discovery founded?
Dalriada Drug Discovery was founded in 2016.
-
Where is Dalriada Drug Discovery headquartered?
Dalriada Drug Discovery is headquartered in Mississauga, Canada.
-
What is the size of Dalriada Drug Discovery?
Dalriada Drug Discovery has 71 total employees.
-
What industry is Dalriada Drug Discovery in?
Dalriada Drug Discovery’s primary industry is Drug Discovery.
-
Is Dalriada Drug Discovery a private or public company?
Dalriada Drug Discovery is a Private company.
-
What is Dalriada Drug Discovery’s current revenue?
The current revenue for Dalriada Drug Discovery is .
-
How much funding has Dalriada Drug Discovery raised over time?
Dalriada Drug Discovery has raised $1.51M.
-
Who are Dalriada Drug Discovery’s investors?
University of Toronto has invested in Dalriada Drug Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process